Patient baseline characteristics in the PROMETCO study: a real-world, prospective longitudinal cohort on the continuum of care of metastatic colorectal cancer

PROMETCO study: Metastatic colorectal cancer (mCRC) treatment patterns of the first 531 enrolled patients

Overall and progression-free survival of patients with metastatic colorectal cancer: A real‑world prospective, longitudinal cohort study on the continuum of care (PROMETCO)

Real-world progression-free and overall survival of patients with metastatic colorectal cancer according to first- and second-line treatment regimen: PROMETCO study

Real-world progression-free and overall survival of patients with metastatic colorectal cancer according to first- and second-line treatment regimen: PROMETCO study

PROMETCO: Real-world characteristics and safety outcomes of patients with metastatic colorectal cancer (mCRC) after two disease progressions, including patients with an ECOG PS ≥2